LAB
Standard BioTools·NASDAQ
--
--(--)
--
--(--)
3.84 / 10
Netural
Capital flow is assessed at 7.68/10, reflecting robust liquidity with Small-inflow trends positive despite overall block-inflow being negative. Analyst coverage is minimal (one report, TD Cowen, Neutral rating), leading to a neutral sentiment score of 3.84/10. The combination of strong fund inflow and weak analyst presence creates a mixed but not outright bearish outlook.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
0%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-11-05
InstitutionTD Cowen
Times predicted1
Historical Win Rate0.0%
What is the market sentiment for LAB?
- LAB holds a Bearish analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 3.84/10 (Netural).
